TCON

TRACON Pharmaceuticals, Inc. Common Stock
TCON

Overview Fund Activity
Delisted

TCON was delisted on the 27th of June, 2024.

Back to rankings

26 hedge funds and large institutions have $29.4M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 5 closing their positions.

Holders
26
Holders Change
+8
Holders Change %
+44.44%
% of All Funds
0.53%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
13
Increased
3
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
IC
1
Ikarian Capital
Texas
$11.2M
2
OM
2
Opaleye Management
Massachusetts
$10.4M
3
BFM
3
Boothbay Fund Management
New York
$1.22M
4
GCP
4
GSA Capital Partners
United Kingdom
$422K
5
Jane Street
5
Jane Street
New York
$200K

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$421K
2
TI
2
Telemetry Investments
New York
$283K
3
Two Sigma Investments
3
Two Sigma Investments
New York
$0
4
Two Sigma Advisers
4
Two Sigma Advisers
New York
$0
5
WS
5
Wedbush Securities
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Millennium Management
26
Millennium Management
New York
$358 -$14 -131 -4%
Two Sigma Investments
27
Two Sigma Investments
New York
– -$174K -4,436 Closed
Two Sigma Advisers
28
Two Sigma Advisers
New York
– -$109K -2,770 Closed
WS
29
Wedbush Securities
California
– -$50K -1,285 Closed
Citadel Advisors
30
Citadel Advisors
Florida
– -$49K -1,238 Closed
Morgan Stanley
31
Morgan Stanley
New York
– -$2K -56 Closed
1
2